Crossject Société Anonyme (EPA:ALCJ)
France · Delayed Price · Currency is EUR 1.986
-0.006 (-0.30%)
Apr 24, 2026, 12:32 PM CET
Crossject Société Anonyme Market Cap
Crossject Société Anonyme has a market cap or net worth of €105.06 million as of April 24, 2026. Its market cap has increased by 155.77% in one year.
Market Cap
105.06M
Enterprise Value
122.42M
Revenue
2.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.99
Market Cap Chart
Since February 20, 2014, Crossject Société Anonyme's market cap has increased from 59.40M to 105.06M, an increase of 76.87%. That is a compound annual growth rate of 4.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 105.06M | -9.04% |
| Dec 31, 2025 | 115.50M | 10.53% |
| Dec 31, 2024 | 104.50M | -44.71% |
| Dec 29, 2023 | 188.99M | 90.83% |
| Dec 30, 2022 | 99.04M | 26.25% |
| Dec 31, 2021 | 78.44M | 0.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 97.83B |
| EssilorLuxottica Société anonyme | 95.40B |
| Sartorius Stedim Biotech | 18.34B |
| Ipsen | 13.09B |
| ABIONYX Pharma | 130.18M |
| Guerbet | 125.52M |
| Euroapi | 121.27M |
| Innate Pharma | 118.04M |